With increasing survival rates across all cancers, survivors represent a growing population that is frequently affected by persistent or permanent hair growth disorders as a result of systemic therapies, radiotherapy, surgical procedures, and therapeutic transplants. These hair disorders include persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, endocrine therapy-induced alopecia and hirsutism, post-surgery alopecia and localized hypertrichosis, alopecia attributed to therapeutic transplants, and to novel anticancer therapies. The information contained in this continuing medical education article should facilitate a better understanding on hair disorders in cancer survivors, so that adequate support and therapies may be provided to cancer survivors.

随着所有癌症生存率的提高，幸存者代表着不断增长的人口，由于系统治疗，放疗，外科手术和治疗性移植，这些人口经常受到持续性或永久性毛发生长疾病的影响。这些头发疾病包括持续性化学疗法引起的脱发，持续性放射疗法引起的脱发，内分泌疗法引起的脱发和多毛症，手术后脱发和局部肥大症，归因于治疗性移植的脱发以及新型抗癌治疗。这篇继续医学教育文章中包含的信息应该有助于更好地了解癌症幸存者的头发疾病，以便可以为癌症幸存者提供足够的支持和疗法。